Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
39
CLDI Quote, Financials, Valuation and Earnings
Last price:
$0.61
Seasonality move
:
-36.42%
Day range:
$0.57 - $0.64
52-week range:
$0.20 - $3.89
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.79x
Volume:
3.1M
Avg. volume:
28.5M
1-year change:
-65.4%
Market cap:
$19.6M
Revenue:
--
EPS (TTM):
-$15.03
Earnings Data
Next earnings date for CLDI
Aug 13
2025
Most recent earnings per share
-$0.18
Missed by $0.03
(May 14/2025)
Consensus Estimate
-$0.15
(May 14/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CLDI Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | -- | -- | -- | -$0.10 | -- |
| 08/13/2025 | Q2 | -- | -- | -- | -$0.11 | -- |
| 05/14/2025 | Q1 | -- | -- | -$0.18 | -$0.15 | -$0.03 |
| 03/31/2025 | Q4 | -- | -- | -$0.20 | -- | -- |
| 11/12/2024 | Q3 | -- | -- | -$0.65 | -- | -- |
| 08/13/2024 | Q2 | -- | -- | -$14.00 | -- | -- |
| 05/14/2024 | Q1 | -- | -- | -$2.03 | -$2.70 | $0.67 |
| 03/15/2024 | Q4 | -- | -- | -$2.32 | -$2.00 | -$0.32 |
| 11/14/2023 | Q3 | -- | -- | -$1.41 | -$1.70 | $0.29 |
| 06/30/2023 | Q2 | -- | -- | -$3.48 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$1.80 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$2.16 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$1.49 | -- | -- |
| 12/31/2021 | Q4 | -- | $405K | -$0.97 | -- | -- |
Calidi Biotherapeutics Earnings Questions
-
How Much did Calidi Biotherapeutics Generate in Revenue Last Quarter?
Calidi Biotherapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Calidi Biotherapeutics Beat Earnings Last Quarter?
Calidi Biotherapeutics announced earnings per share of -$0.18 which represents a miss of analyst forecast a -$0.15 per share.
-
Is Calidi Biotherapeutics Profitable?
Calidi Biotherapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Calidi Biotherapeutics EPS Next Year?
Calidi Biotherapeutics's earnings are forecast to decrease from -$2.97 per share to -$0.45 per share next year representing a decrease of -84.85%.
-
When is Calidi Biotherapeutics's Earnings Date?
Calidi Biotherapeutics's next earnings date is August 13, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
72
SBET alert for Jul 18
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
